Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Mouse Anti-Canine Aldose Reductase Monoclonal Antibody

Cat. No.VD8N44

Product TypeAnimal-targeted Antibodies

Size

Product Overview

BioVenic mouse monoclonal antibody is specific for canine aldose reductase. It can be applied to WB assay of canine aldose reductase.

Specifications

Application WB
Clonality Monoclonal
Classification Primary Antibody
Clone G3N8
Host Mouse
Target Species Canine
Species Reactivity Canine
Specificity Canine Aldose Reductase
Isotype IgG
Immunogen Purified recombinant canine aldose reductase protein fragments
Concentration 1 mg/mL
Conjugation Unconjugated
Physical State Liquid

Target Information

Canine aldose reductase (cALR) is an enzyme belonging to the aldo-keto reductase (AKR) superfamily, which is involved in the conversion of sugars to their corresponding sugar alcohols. This enzyme is particularly important in the context of diabetes mellitus, as it helps regulate the levels of sorbitol, a polyol that can accumulate in tissues and contribute to diabetic complications when present in excess. cALR is also implicated in the detoxification of reactive aldehydes, which are harmful molecules produced during oxidative stress and lipid peroxidation.

Target Canine Aldose Reductase
Target Synonym AKR1B1; ALDR1
Gene ID 607537
UniProt ID A0A8C0P001

Shipping and Storage

This product is shipped with ice gel packs. Store at -20°C (up to 12 months) on receipt. Avoid repeated freezing and thawing as this may denature the antibody.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

  1. Williams, David L. "Effect of oral alpha lipoic acid in preventing the genesis of canine diabetic cataract: a preliminary study." Veterinary Sciences 4.1 (2017): 18.
Inquiry Basket